Search Results - "Mendoza, Andres Moran"
-
1
Circulating soluble levels of MIF in women with breast cancer in the molecular subtypes: relationship with Th17 cytokine profile
Published in Clinical and experimental medicine (01-08-2019)“…Breast cancer (BC) is a health problem worldwide; there is evidence that inflammatory cytokines are increased in BC. Macrophage migration inhibitory factor…”
Get full text
Journal Article -
2
HLA-G 14 bp Ins/Del (rs66554220) Variant Is Not Associated with Breast Cancer in Women from Western Mexico
Published in Current issues in molecular biology (16-08-2023)“…HLA-G is a physiology and pathologic immunomodulator detrimentally related to cancer. Its gene is heavily transcriptionally and post-transcriptionally…”
Get full text
Journal Article -
3
Association of the genetic variants (‐794 CATT5‐8 and ‐173 G > C) of macrophage migration inhibitory factor (MIF) with higher soluble levels of MIF and TNFα in women with breast cancer
Published in Journal of clinical laboratory analysis (01-05-2020)“…Background Functional variants ‐173 G > C (rs755622) and ‐794CATT5‐8 (rs5844572) MIF gene have been associated with the risk in several types of cancer, as…”
Get full text
Journal Article -
4
Association of rs2234693 and rs9340799 polymorphisms of ESR1 gene in breast cancer of Mexican population
Published in Journal of B.U.ON. : official journal of the Balkan Union of Oncology (01-09-2019)“…The rs2234693 and rs9340799 ESR1 polymorphisms have shown contradictory results in studies of breast cancer (BC). The purpose of this study was to determine…”
Get more information
Journal Article -
5
Transcriptomic Analysis of Breast Cancer Patients Sensitive and Resistant to Chemotherapy: Looking for Overall Survival and Drug Resistance Biomarkers
Published in Technology in cancer research & treatment (01-01-2022)“…Worldwide breast cancer ranks first in mortality and incidence rates in women over 20 years old. Rather than one disease, breast cancer is a heterogeneous…”
Get full text
Journal Article -
6
A gene expression signature in HER2+ breast cancer patients related to neoadjuvant chemotherapy resistance, overall survival, and disease-free survival
Published in Frontiers in genetics (21-10-2022)“…Breast cancer ranks first in terms of mortality and incidence rates worldwide among women. The HER2+ molecular subtype is one of the most aggressive subtypes;…”
Get full text
Journal Article -
7
Recommendations on the pharmacological treatment of epithelial ovarian cancer in Mexico
Published in Gaceta médica de México (20-12-2021)“…Ovarian cancer is the third most frequent gynaecological malignancy worldwide and in Mexico, with a high mortality rate, due to that in many cases its…”
Get full text
Journal Article -
8
Socioeconomic, Clinical, and Molecular Features of Breast Cancer Influence Overall Survival of Latin American Women
Published in Frontiers in oncology (08-03-2022)“…Molecular profile of breast cancer in Latin-American women was studied in five countries: Argentina, Brazil, Chile, Mexico, and Uruguay. Data about…”
Get full text
Journal Article -
9
ADXS11-001 LM-LLO as specific immunotherapy in cervical cancer
Published in Human vaccines & immunotherapeutics (03-08-2021)“…Human papillomavirus (HPV) infection is a well-known cause of cervical cancer. Therapeutic cancer vaccines are part of the current therapeutic options for…”
Get full text
Journal Article -
10
Abstract 608: Molecular features of breast cancer involved in classification and prognosis of a multi-country Latin American cohort: The US-LACRN-MPBCS breast cancer cohort
Published in Cancer research (Chicago, Ill.) (01-07-2021)“…Although gene expression-derived PAM50 intrinsic subtypes (LumA, LumB, HER2E and Basal) were reported in Latin American breast cancer, most studies did not…”
Get full text
Journal Article -
11
Implementing Standard Diagnosis and Treatment for Locally Advanced Breast Cancer Through Global Research in Latin America: Results From a Multicountry Pragmatic Trial
Published in JCO global oncology (01-05-2024)“…Breast cancer mortality rates in Latin America (LA) are higher than those in the United States, possibly because of advanced disease presentation, health care…”
Get full text
Journal Article -
12
Induction chemotherapy (ICh) followed by concurrent chemoradiotherapy (ChR) in locally advanced squamous cell carcinoma of head and neck (SCCHN): Experience in a Mexican institute
Published in Journal of clinical oncology (20-05-2013)“…Abstract only e17031 Background: ICh has taken an important role in the treatment of locally advanced disease, but it has not been recognized in which patients…”
Get full text
Journal Article -
13
Adaptación y evaluación de la eficacia de un programa psicoeducativo de navegación para disminuir síntomas de ansiedad y depresión en mujeres mexicanas con cáncer de mama
Published in Psicooncología (01-01-2023)“…Objetivo El cáncer de mama (CAM) es un problema de salud pública mundial. La ansiedad y depresión son las principales comorbilidades que aquejan a este sector,…”
Get full text
Journal Article -
14
The Transcriptomic Portrait of Locally Advanced Breast Cancer and Its Prognostic Value in a Multi-Country Cohort of Latin American Patients
Published in Frontiers in oncology (22-03-2022)“…Most molecular-based published studies on breast cancer do not adequately represent the unique and diverse genetic admixture of the Latin American population…”
Get full text
Journal Article -
15
Recomendaciones sobre el tratamiento farmacológico del cáncer de ovario epitelial en México
Published in Gaceta médica de México (20-12-2021)Get full text
Journal Article -
16
Recomendaciones sobre el tratamiento farmacológico del cáncer de ovario epitelial en México
Published in Gaceta médica de México (28-03-2023)Get full text
Journal Article -
17
Tumores neuroendocrinos: experiencia de 6 años en un centro de tercer nivel
Published in Gaceta Mexicana de oncología (01-05-2015)“…Los tumores neuroendocrinos son poco frecuentes, pero su incidencia está aumentando gradualmente. En el presente estudio se evaluaron las características…”
Get full text
Journal Article -
18
Third National Ovarian Consensus. 2011. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México "GICOM"
Published in Revista de investigacion clinica (01-11-2011)“…Ovarian cancer (OC) is the third most common gynecologic malignancy worldwide. Most of cases it is of epithelial origin. At the present time there is not a…”
Get full text
Journal Article -
19
The first Mexican consensus of endometrial cancer. Grupo de Investigación en Cáncer de Ovario y Tumores Ginecológicos de México
Published in Revista de investigacion clinica (01-11-2010)“…Endometrial cancer (EC) is the second most common gynecologic malignancy worldwide in the peri and postmenopausal period. Most often for the endometrioid…”
Get full text
Journal Article